Ignite Creation Date:
2024-05-05 @ 9:04 PM
Last Modification Date:
2024-10-26 @ 9:59 AM
Study NCT ID:
NCT00809965
Status:
COMPLETED
Last Update Posted:
2014-09-17
First Post:
2008-12-16
Brief Title:
An Efficacy and Safety Study for Rivaroxaban in Patients With Acute Coronary Syndrome
Sponsor:
Johnson Johnson Pharmaceutical Research Development LLC
Organization:
Johnson Johnson Pharmaceutical Research Development LLC
Organization Data
Organization:
Johnson Johnson Pharmaceutical Research Development LLC
Class:
INDUSTRY
Study ID:
CR014710
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Johnson Johnson Pharmaceutical Research Development LLC
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Bayer | INDUSTRY |